StemCells has struck a licensing deal with Canada's Stem Cell Therapeutics. Stem Cell Therapeutics will pay StemCells an unspecified upfront payment and milestone fees for neural stem cell technology. StemCells in turn will get access to Stem Cell Therapeutics' IP portfolio to develop new drugs and tests. StemCells is developing therapies using adult stem cells.
- here's the AP report on the stem cell pact